| 000 | 01276 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516230422.0 | ||
| 264 | 0 | _c20150514 | |
| 008 | 201505s 0 0 eng d | ||
| 022 | _a1834-7819 | ||
| 024 | 7 |
_a10.1111/adj.12217 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aO'Halloran, M | |
| 245 | 0 | 0 |
_aDenosumab and osteonecrosis of the jaws - the pharmacology, pathogenesis and a report of two cases. _h[electronic resource] |
| 260 |
_bAustralian dental journal _cDec 2014 |
||
| 300 |
_a516-9 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
| 650 | 0 | 4 |
_aBisphosphonate-Associated Osteonecrosis of the Jaw _xdiagnosis |
| 650 | 0 | 4 | _aDenosumab |
| 650 | 0 | 4 |
_aDiphosphonates _xpharmacokinetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJaw Diseases _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteonecrosis _xchemically induced |
| 650 | 0 | 4 |
_aRANK Ligand _xantagonists & inhibitors |
| 700 | 1 | _aBoyd, N M | |
| 700 | 1 | _aSmith, A | |
| 773 | 0 |
_tAustralian dental journal _gvol. 59 _gno. 4 _gp. 516-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/adj.12217 _zAvailable from publisher's website |
| 999 |
_c24106347 _d24106347 |
||